Roy Baynes, Merck
Merck's 15-strain pneumonia shot matches Prevnar 13 in late-stage infant study, but Pfizer's next-gen shot looms
In order to keep the heat on Pfizer and its next-generation pneumococcal vaccine, Merck knows it will need to get creative to give its 15 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
